SCHEMBL20614435

SCHEMBL20614435

O=C(O)c1cc2ccc(S)cc2s1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.59
GPR35 Q9HC97 3/20 0.55
TBXAS1 P24557 1/20 0.46
HDAC1 Q13547 8/20 0.44
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC7 Q8WUI4 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC10 Q969S8 2/20 0.44
HDAC11 Q96DB2 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC9 Q9UKV0 2/20 0.44
HDAC5 Q9UQL6 2/20 0.44
PTPN2 P17706 2/20 0.41
HSD17B1 P14061 1/20 0.41
RPA1 P27694 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20097866 0.85 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL15697571 0.79 GPR35 (0.61) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL8250577 0.79 BCL2L1 (0.61) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL5600103 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL156320 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL31435451 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL1090344 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL20614582 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL498133 0.78 BCL2L1 (0.59) BCL2L1GPR35TBXAS1HDAC1HDAC3
SCHEMBL121300 0.78 HDAC1 (0.70) BCL2L1GPR35TBXAS1HDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421464-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2019-01-02 EP disclosed